Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement
XPH
US Health Care
Passive
NYSE listed

State Street SPDR S&P Pharmaceuticals ETF

This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities

XPH performance and flow charts

Last update 7/28/2026 at 1:30 PM
Live
Closed
Last price
$69.00
+$0.46 (+0.67%) Yesterday

Performance

-2.00.02.04.06.0%Jun 29Jul 7Jul 14Jul 21Jul 28

Flows

0 M10 M20 M30 M40 M50 M60 M
1 day price range
$68.23
$69.10
52 week price range
$41.26
$70.01
1W perf
+0.26%
YTD perf
+23.16%
YTD flows
+$179M
AuM
$486M
E/R
0.35%
TTM yield
0.49%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of July 28, 2026
1M3MYTD1Y3Y5Y
Perf.+3.93%+20.29%+23.16%+61.68%+64.08%+38.34%
Flows+$65M+$63M+$179M+$203M+$132M+$144M
Data as of July 28, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The State Street SPDR S&P Pharmaceuticals ETF is built to track the S&P Pharmaceuticals Select Industry Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderState Street Investment Management
N° of holdings63
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 19, 2006
ESGNo
TrackinsightTrackinsight

More data and info about XPH on Trackinsight

Exposure

Data as of June 30, 2026

Diversification

29.74%

Total weight of top 15 holdings out of 63

Top 15 Holdings

MBX Biosciences, Inc.
2.72%
Alumis, Inc.
2.14%
Trevi Therapeutics, Inc.
2.12%
Enliven Therapeutics, Inc.
2.09%
Amylyx Pharmaceuticals, Inc.
2.04%
Veradermics, Inc.
2.02%
Ligand Pharmaceuticals, Inc.
1.94%
Nuvation Bio, Inc.
1.89%
Edgewise Therapeutics, Inc.
1.88%
Nektar Therapeutics
1.88%
Liquidia Corp.
1.86%
Maze Therapeutics, Inc.
1.85%
Harrow, Inc.
1.81%
EyePoint, Inc.
1.77%
Amneal Pharmaceuticals, Inc.
1.72%

Sectors

Healthcare
94.73%
Other
5.27%

Countries

USA
90.15%
Other
9.85%
Advertisement

Trading data

Last sale
7/28/2026 at 1:30 PM
$69.00
Previous close
$68.54
Consolidated volume
07/28/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+24.37%+22.20%+20.24%+20.86%
Max drawdown
-8.13%-11.78%-23.45%-31.59%
Max drawdown duration
41d50d322d1566d
Time to recover
30d18d173d729d

Replication quality

Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about XPH

What type of ETF is XPH?

XPH is a Passive ETF that provides exposure to Equity assets. It is managed by State Street Investment Management.

What index does XPH track?

XPH tracks the S&P Pharmaceuticals Select Industry Total Return Index - USD, aiming to replicate its performance through full replication.

What does XPH invest in?

This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities. It is part of the segment: US Health Care.

What is the expense ratio of XPH?

The total expense ratio (TER) of XPH is 0.35%, representing the annual fee charged by the fund manager.

When was XPH launched?

XPH was launched on June 19, 2006, marking its entry into the ETF market.

Who is the issuer of XPH?

XPH is issued by State Street Investment Management.

What is the AUM of XPH?

As of July 28, 2026, XPH manages $485.98 M, reflecting the total assets held in the fund.

How has XPH performed recently?

As of July 28, 2026, XPH delivered a return of 3.93% over the past month (1M performance), 20.29% over the past three months (3M), and 23.16% year-to-date (YTD).

What are the recent fund flows for XPH?

As of July 28, 2026, XPH has seen net flows of +$65M in the past month (1M flow) and +$179M year-to-date (YTD).

Does XPH pay dividends?

As of July 28, 2026, XPH has a trailing 12-month distribution yield of 0.49%.

How many holdings are in XPH

As of June 30, 2026, XPH holds 63 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is XPH?

As of June 30, 2026, XPH holds 63 securities, with 29.74% of its assets concentrated in its top 15 holdings.

What are the top holdings of XPH?

As of June 30, 2026, XPH holds a portfolio of 63 underlyings, with its largest positions including MBX Biosciences, Inc., Alumis, Inc. and Trevi Therapeutics, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does XPH invest in?

As of June 30, 2026, XPH has its largest geographic exposures in USA.

What sectors or themes does XPH focus on?

As of June 30, 2026, XPH is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 20, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 13, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 14, 2026
First Look ETF: Cash Deployment, Bond, and Hedged ETFs

First Look ETF

First Look ETF: Cash Deployment, Bond, and Hedged ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · July 10, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 6, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 7, 2026

Browse all educational columns

Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder